The antileishmanial activity of the antarctic brown algaAscoseira mirabilisSkottsberg

Author(s)

Clementino, Leandro da Costa ; Oda, Fernando Bombarda ; Teixeira, Thaiz Rodrigues ; Tavares, Renata Spagolla Napoleao ; Colepicolo, Pio ; dos Santos, Andre Gonzaga ; Debonsi, Hosana Maria ; Graminha, Marcia A. S.

• Document type: Journal article
• Source: NATURAL PRODUCT RESEARCH; v. 35, n. 23, p. 5-pg., 2020-06-19.

Abstract

Leishmaniasis is a group of diseases that have limited and high toxic therapeutic options. Herein, we evaluated the antileishmanial potential and cytotoxicity of hexanic extract obtained from the Antarctic brown algaAscoseira mirabilisusing bioguided fractionation againstLeishmania amazonensisand murine macrophages, which was fractionated by SPE, yielding seven fractions (F1-F7). The fraction F6 showed good anti-amastigote activity (IC50 = 73.4 +/- 0.4 mu g mL(-1)) and low cytotoxicity (CC50 > 100 mu g mL(-1)). Thus, in order to identify the bioactive constituent(s) of F6, the fraction was separated in a semipreparative HPLC, yielding four fractions (F6.1-F6.4). F6.2 was the most bioactive fraction (IC50 = 66.5 +/- 4.5 mu g mL(-1)) and GC-MS analyses revealed that the compounds octadecane, propanoic acid, 1-monomyristin and azelaic acid correspond to 61% of its composition. These data show for the first time the antileishmanial potential of the Antarctic algaA. mirabilis. (AU)

• FAPESP's process: 17/03552-5 - Leishmaniasis: from screening to the study of mechanisms of action, a contribution to the discovery of new bioactive molecules
• Grantee: Marcia Aparecida Silva Graminha
• Support Opportunities: Regular Research Grants